{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T18:04:28Z","timestamp":1779645868338,"version":"3.53.1"},"reference-count":0,"publisher":"Tunisian Society of Medical Sciences","issue":"05","license":[{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tunis Med"],"abstract":"<jats:p>Introduction: Hemoptysis is a potentially life-threatening symptom that requires prompt evaluation and management. Its recurrence can be as distressing as the initial episode and represents a significant clinical concern.Aim: This study aimed to identify predictors of hemoptysis recurrence outside the hospital setting.Methods: We conducted a retrospective, longitudinal, descriptive, and analytical study including all patients hospitalized for hemoptysis in the Pneumology Department of Charles Nicolle Hospital, Tunis, between January 2015 and June 2022. The follow-up period extended from the firsthospitalization to the last medical consultation, with a minimum duration of one year. Patients who experienced recurrence during follow-up were analyzed to identify clinical, etiological, and therapeutic factors associated with hemoptysis recurrence.Results: A total of 200 patients were included, with a mean age of 52.5 \u00b1 15.8 years (range: 18\u201390), and a marked male predominance (83.5%). Active smoking was reported in 83.5% of patients. Drug use was noted in 13% of cases, and 15% had high-risk behaviors. Comorbidities were present in 52% of patients, predominantly cardiovascular diseases. Five patients (2.5%) were receiving vitamin K antagonists, and eight (4%) were on antiplatelet therapy. Multivariate logistic regression analysis identified cardiovascular comorbidities (OR = 2.2), bronchiectasis (OR = 9.8), and antiplatelet therapy (OR= 3) as independent predictors of hemoptysis recurrence. Additionally, markers of initial episode severity, including acute anemia requiring blood transfusion (OR = 2.5) and the need for octreotide (OR = 8.2), were significantly associated with an increased risk of out-of-hospital recurrence.Conclusion: These findings underscore the importance of risk stratification, close follow-up, and individualized management in patients at high risk of hemoptysis recurrence. Early identification of predictive factors may help optimize preventive strategies and improve clinical outcomes.<\/jats:p>","DOI":"10.62438\/tunismed.v104i05.6024","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T17:49:50Z","timestamp":1779644990000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictive factors of hemoptysis recurrence after hospital discharge"],"prefix":"10.62438","volume":"104","author":[{"given":"Emna","family":"Ben Jemia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Nemsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Ouertani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Sadok","family":"Boudaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarra","family":"Lamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Hedhli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosr","family":"Ben Attig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna","family":"Azza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihen","family":"Ben Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Zaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"31112","published-online":{"date-parts":[[2026,5,24]]},"container-title":["La Tunisie M\u00e9dicale"],"original-title":[],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T17:49:50Z","timestamp":1779644990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.latunisiemedicale.com\/index.php\/tunismed\/article\/view\/6024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":0,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2026,5,24]]}},"URL":"https:\/\/doi.org\/10.62438\/tunismed.v104i05.6024","relation":{},"ISSN":["2724-7031","0041-4131"],"issn-type":[{"value":"2724-7031","type":"electronic"},{"value":"0041-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,24]]}}}